Ibotta, Inc.IBTANYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank60
3Y CAGR-43.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-43.6%/yr
Quarterly compound
Percentile
P60
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 20251.60%
Q3 2025-4.90%
Q2 2025-18.40%
Q1 202514.22%
Q4 2024-2.86%
Q3 2024-7.08%
Q2 202428.48%
Q1 2024-0.36%
Q4 202310.48%
Q3 20231.40%
Q2 20234.49%
Q1 20235.01%
Q4 20228.90%
Q3 2022-0.51%
Q2 2022-5.83%
Q1 20220.00%